Varshabhu: Traditional Uses, Evidence & Safety

TL;DR

Varshabhu is identified with Trianthema portulacastrum, a monsoon weed used in Ayurveda for liver and urinary complaints. The modern evidence is a handful of animal studies: an ethanolic leaf extract protected rats against aflatoxin-induced liver damage about as well as silymarin, and other work reports radioprotective effects in mice. No human trial exists; human safety is unstudied.

What it is

Varshabhu ("born of the rains") is Trianthema portulacastrum L., in the Aizoaceae family, a prostrate succulent weed that appears with the monsoon across India. Ayurvedic pharmacy uses the whole plant, classically in liver and urinary formulations. Its studied chemistry includes ecdysteroids, flavonoids, and alkaloids, the compounds investigated in the animal pharmacology below.

Traditional use

Ayurvedic texts use varshabhu for yakrit (liver) disorders, shotha (swelling), and mutra (urinary) complaints, often in compound formulations. Folk practice uses the fresh plant as a vegetable and poultice. These are traditional claims, not clinical proof.

What modern research says

Liver protection against aflatoxin in rats

In a controlled animal study, rats given aflatoxin B1 (a potent liver toxin) developed marked liver injury with raised liver enzymes and depleted antioxidant defenses. Pretreatment with ethanolic T. portulacastrum leaf extract (100 mg/kg orally for 7 days) reversed these changes to near normal, with protection comparable to the reference drug silymarin at the same dose. The authors called the extract a potent hepatoprotectant in this model (controlled animal study) (Banu et al., Indian Journal of Clinical Biochemistry, 2009; PubMed).

Radioprotective effects in mice

Published work in the Indian Journal of Experimental Biology reports that T. portulacastrum extracts reduced radiation-induced damage in mice. Like the liver study, this is preclinical pharmacology in a specific injury model (animal study) (IJEB radioprotection study).

What the evidence does not support (yet)

No human trial supports varshabhu for liver disease, hepatitis, swelling, or urinary complaints. Rat protection against a specific toxin does not mean human liver benefits, and "as potent as silymarin" describes one animal model, not clinical equivalence.

Safety & contraindications

There are no published human safety studies of varshabhu. Animal research doses do not translate to human dosing. Do not use varshabhu for liver disease, hepatitis, or jaundice instead of diagnosis and proven treatment; liver disease needs proper medical assessment. Avoid medicinal use during pregnancy and lactation on precautionary grounds.

FAQs

What is varshabhu good for in Ayurveda?

Traditionally for liver complaints, swelling, and urinary disorders. None of these uses has human-trial support.

Does it protect the liver?

In rats poisoned with aflatoxin, the leaf extract did. Whether it does anything for human liver disease is unknown.

Can I eat it as a vegetable?

It is eaten as a monsoon green in some regions, but food use and medicinal-dose use are different things, and medicinal safety is unstudied.

Why no dose in this article?

No pharmacopoeia dose or clinical trial dose exists for standalone varshabhu. Our editorial rule omits dosing rather than inventing it.

Sources

Ethanolic leaf extract of Trianthema portulacastrum protected rats against aflatoxin B1 liver damage comparably to silymarin: Banu et al., Indian J Clin Biochem 2009 (PubMed 23105844).

Radioprotective effects of T. portulacastrum in mice were reported in the Indian Journal of Experimental Biology: NISCPR repository record.

Disclaimer

Varshabhu has no proven human efficacy and no established human safety profile. Do not use it for liver disease or jaundice instead of evidence-based care. This article is educational, not medical advice.